Want to know more about Iris-Achats? Create and verify your free account to access full information.Create your free account

🏛️Iris-Achats

General information

The entity called Iris-Achats is part of the entity of the public sector of Belgium that carries out public procurement, that is, that invests part of the assigned budget in hiring people or companies to fulfill its objectives.

CountryBelgium Postal code1060 Total contracted amountEUR 28,476,218.24 Number of procurement processes53

Most frequent suppliers

The entity Iris-Achats has established relationships with 12 different suppliers through its procurement activities.

This diversity in suppliers promotes competition, ensures better value for money, and reduces dependency on single vendors.

SupplierNo. ContractsTotal amount
🇧🇪 Novartis Pharma3523,707,815 EUR
🇧🇪 Accord Healthcare bvba41,490,000 EUR
🇧🇪 GE Healthcare3240,425 EUR
🇧🇪 Canon Medical Systems Belgium NV2156,075 EUR
🇧🇪 Philips Belgium Commercial NV2170,489 EUR

Contracts

This entity has participated in 53 contracts for a total value of EUR 28,476,218.24

These contracts represent the entity's investment in goods, services, and infrastructure to fulfill its public service objectives.

# Contracts
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
DescriptionSupplierAmountDate
🇧🇪 Everolimus farmaceutische specialiteiten, erenumab, indacaterol/mometason, secukinumab, deferoxamine (mesilaat), indacaterol/glycopyrronium (bromide)/mometason, sacubitril/valsartan, vildagliptine/metformine (hydrochloride), vildagliptine, canakinumab, ruxolitinib (fosfaat), ribociclib, ranibizumab, siponimod, trametinib (dimethylsulfoxide), methylergometrine (maleaat), ...🇧🇪 Novartis Pharma4,049 EUR2023-10-20
🇧🇪 Everolimus farmaceutische specialiteiten, erenumab, indacaterol/mometason, secukinumab, deferoxamine (mesilaat), indacaterol/glycopyrronium (bromide)/mometason, sacubitril/valsartan, vildagliptine/metformine (hydrochloride), vildagliptine, canakinumab, ruxolitinib (fosfaat), ribociclib, ranibizumab, siponimod, trametinib (dimethylsulfoxide), methylergometrine (maleaat), ...🇧🇪 Novartis Pharma3,391,350 EUR2023-10-20
🇧🇪 Everolimus farmaceutische specialiteiten, erenumab, indacaterol/mometason, secukinumab, deferoxamine (mesilaat), indacaterol/glycopyrronium (bromide)/mometason, sacubitril/valsartan, vildagliptine/metformine (hydrochloride), vildagliptine, canakinumab, ruxolitinib (fosfaat), ribociclib, ranibizumab, siponimod, trametinib (dimethylsulfoxide), methylergometrine (maleaat), ...🇧🇪 Novartis Pharma1,879,003 EUR2023-10-20
🇧🇪 Everolimus farmaceutische specialiteiten, erenumab, indacaterol/mometason, secukinumab, deferoxamine (mesilaat), indacaterol/glycopyrronium (bromide)/mometason, sacubitril/valsartan, vildagliptine/metformine (hydrochloride), vildagliptine, canakinumab, ruxolitinib (fosfaat), ribociclib, ranibizumab, siponimod, trametinib (dimethylsulfoxide), methylergometrine (maleaat), ...🇧🇪 Novartis Pharma2,164,668 EUR2023-10-20
🇧🇪 Everolimus farmaceutische specialiteiten, erenumab, indacaterol/mometason, secukinumab, deferoxamine (mesilaat), indacaterol/glycopyrronium (bromide)/mometason, sacubitril/valsartan, vildagliptine/metformine (hydrochloride), vildagliptine, canakinumab, ruxolitinib (fosfaat), ribociclib, ranibizumab, siponimod, trametinib (dimethylsulfoxide), methylergometrine (maleaat), ...🇧🇪 Novartis Pharma3,770,004 EUR2023-10-20

Market context and opportunities

As part of the public sector in Guatemala, this entity plays a crucial role in public service delivery and infrastructure development.

The entity Iris-Achats regularly publishes procurement opportunities for suppliers interested in providing goods and services to the public sector.

With 53 contracts and a total value of 28,476,218.24 Q, this entity demonstrates active participation in public procurement.

The entity Iris-Achats has maintained consistent procurement activity over 22 years, showing stable budget allocation and project management.

Public sector context

As a entity entity, Iris-Achats serves essential public functions and contributes to Belgium's development through responsible procurement practices.

This entity is committed to transparency in public procurement, making contract information publicly available as required by Belgium law.

Citizens can monitor the procurement activities of Iris-Achats through public databases and transparency portals.

The entity Iris-Achats has awarded 53 contracts, all of which are publicly accessible for citizen oversight and accountability.

Data sources

Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.

Published byOpentender.eu
Countries231
LicenseCC BY-NC-SA 4.0
Year range2003 - 2025
Update statusNot updated (2025-01-01)
OpenTender obtains information from the procurement portal of the European Union.
This record last updated2020-03-19